Export 62 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is Y  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Y. Yamada, Shinkawa, K., Kobayashi, M., Caggiano, V., Nemoto, M., Nemoto, K., and Arai, T., Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment., J Alzheimers Dis, vol. 84, no. 1, pp. 315-327, 2021.
V. Yamamoto, Bolanos, J. F., Fiallos, J., Strand, S. E., Morris, K., Shahrokhinia, S., Cushing, T. R., Hopp, L., Tiwari, A., Hariri, R., Sokolov, R., Wheeler, C., Kaushik, A., Elsayegh, A., Eliashiv, D., Hedrick, R., Jafari, B., J Johnson, P., Khorsandi, M., Gonzalez, N., Balakhani, G., Lahiri, S., Ghavidel, K., Amaya, M., Kloor, H., Hussain, N., Huang, E., Cormier, J., J Ashford, W., Wang, J. C., Yaghobian, S., Khorrami, P., Shamloo, B., Moon, C., Shadi, P., and Kateb, B., COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications., J Alzheimers Dis, vol. 77, no. 2, pp. 459-504, 2020.
T. Yamasaki, Horie, S., Ohyagi, Y., Tanaka, E., Nakamura, N., Goto, Y., Kanba, S., Kira, J. - I., and Tobimatsu, S., A Potential VEP Biomarker for Mild Cognitive Impairment: Evidence from Selective Visual Deficit of Higher-Level Dorsal Pathway., J Alzheimers Dis, vol. 53, no. 2, pp. 661-76, 2016.
S. Yamashita, Kiko, T., Fujiwara, H., Hashimoto, M., Nakagawa, K., Kinoshita, M., Furukawa, K., Arai, H., and Miyazawa, T., Alterations in the Levels of Amyloid-β, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-β and These Lipids., J Alzheimers Dis, vol. 50, no. 2, pp. 527-37, 2016.
C. Yamazaki, Tamaoki, T., Nunomura, A., Tamai, K., Yasuda, K., and Motohashi, N., Plasma Amyloid-β and Alzheimer's Disease-Related Changes in Late-Life Depression., J Alzheimers Dis, vol. 58, no. 2, pp. 349-354, 2017.
K. Yamazaki, Yoshino, Y., Mori, T., Yoshida, T., Ozaki, Y., Sao, T., Mori, Y., Ochi, S., Iga, J. - I., and Ueno, S. - I., Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 57, no. 1, pp. 171-181, 2017.
A. Yamoah, Tripathi, P., Sechi, A., Köhler, C., Guo, H., Chandrasekar, A., Nolte, K. Wilhelm, Wruck, C. Jan, Katona, I., Anink, J., Troost, D., Aronica, E., Steinbusch, H., Weis, J., and Goswami, A., Aggregates of RNA Binding Proteins and ER Chaperones Linked to Exosomes in Granulovacuolar Degeneration of the Alzheimer's Disease Brain., J Alzheimers Dis, vol. 75, no. 1, pp. 139-156, 2020.
T. Yan, Wang, L., Gao, J., Siedlak, S. L., Huntley, M. L., Termsarasab, P., Perry, G., Chen, S. G., and Wang, X., Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease., J Alzheimers Dis, vol. 63, no. 1, pp. 157-165, 2018.
Y. Yan, Wu, X., Wang, X., Geng, Z., Wang, L., Xiao, G., Wu, Y., Zhou, S., Liao, R., Wei, L., Tian, Y., and Wang, K., The Retinal Vessel Density Can Reflect Cognitive Function in Patients with Alzheimer's Disease: Evidence from Optical Coherence Tomography Angiography., J Alzheimers Dis, vol. 79, no. 3, pp. 1307-1316, 2021.
C. -cui Yang, Kuai, X. -xian, bin Gao, W. -, Yu, J. -chun, Wang, Q., Li, L., and Zhang, L., Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration., J Alzheimers Dis, vol. 51, no. 1, pp. 33-44, 2016.
H. Yang, Hou, T., Wang, W., Luo, Y., Yan, F., and Jia, J., The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L)., J Alzheimers Dis, vol. 62, no. 4, pp. 1609-1621, 2018.
J. Yang, Zhang, R., Shi, C., Mao, C., Yang, Z., Suo, Z., Torp, R., and Xu, Y., AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 57, no. 1, pp. 157-169, 2017.
Y. Yang, Halliday, G. M., Hodges, J. R., and Tan, R. H., von Economo Neuron Density and Thalamus Volumes in Behavioral Deficits in Frontotemporal Dementia Cases with and without a C9ORF72 Repeat Expansion., J Alzheimers Dis, vol. 58, no. 3, pp. 701-709, 2017.
Y. Yang and Wang, J. - Z., Nature of Tau-Associated Neurodegeneration and the Molecular Mechanisms., J Alzheimers Dis, vol. 62, no. 3, pp. 1305-1317, 2018.
H. - S. Yang, Chhatwal, J. P., Xu, J., White, C. C., Hanseeuw, B., Rabin, J. S., Papp, K. V., Buckley, R. F., Schultz, A. P., Properzi, M. J., Gatchel, J. R., Amariglio, R. E., Donovan, N. J., Mormino, E. C., Hedden, T., Marshall, G. A., Rentz, D. M., Johnson, K. A., De Jager, P. L., and Sperling, R. A., An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults., J Alzheimers Dis, vol. 68, no. 3, pp. 1161-1170, 2019.
C. - C. Yang, Chiu, M. - J., Chen, T. - F., Chang, H. - L., Liu, B. - H., and Yang, S. - Y., Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 4, pp. 1323-1332, 2018.
C. Yang, Huang, X., Huang, X., Mai, H., Li, J., Jiang, T., Wang, X., and Lü, T., Aquaporin-4 and Alzheimer's Disease., J Alzheimers Dis, vol. 52, no. 2, pp. 391-402, 2016.
Q. Yao, Jiang, G. - X., Zhou, Z. - M., Chen, J. - M., and Cheng, Q., Metabolic Syndrome and Mild Cognitive Impairment: A Case-Control Study among Elderly in a Shanghai Suburb., J Alzheimers Dis, vol. 51, no. 4, pp. 1175-82, 2016.
F. Yao, Hong, X., Li, S., Zhang, Y., Zhao, Q., Du, W., Wang, Y., and Ni, J., Urine-Based Biomarkers for Alzheimer's Disease Identified Through Coupling Computational and Experimental Methods., J Alzheimers Dis, vol. 65, no. 2, pp. 421-431, 2018.
M. Yarchoan, James, B. D., Shah, R. C., Arvanitakis, Z., Wilson, R. S., Schneider, J., Bennett, D. A., and Arnold, S. E., Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology., J Alzheimers Dis, vol. 56, no. 2, pp. 699-706, 2017.
S. Yasar, Moored, K. D., Adam, A., Zabel, F., Chuang, Y. - F., Varma, V. R., and Carlson, M. C., Angiotensin II Blood Levels Are Associated with Smaller Hippocampal and Cortical Volumes in Cognitively Normal Older Adults., J Alzheimers Dis, vol. 75, no. 2, pp. 521-529, 2020.
S. Yasar, Varma, V. R., Harris, G. C., and Carlson, M. C., Associations of Angiotensin Converting Enzyme-1 and Angiotensin II Blood Levels and Cognitive Function., J Alzheimers Dis, vol. 63, no. 2, pp. 655-664, 2018.
N. Yassi, Hilal, S., Xia, Y., Lim, Y. Ying, Watson, R., Kuijf, H., Fowler, C., Yates, P., Maruff, P., Martins, R., Ames, D., Chen, C., Rowe, C., Villemagne, V., Salvado, O., Desmond, P. M., and Masters, C. L., Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease., J Alzheimers Dis, vol. 73, no. 3, pp. 897-907, 2020.
I. Yasue, Matsunaga, S., Kishi, T., Fujita, K., and Iwata, N., Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators., J Alzheimers Dis, vol. 50, no. 3, pp. 733-40, 2016.
J. A. Yates, Clare, L., and Woods, R. T., What is the Relationship between Health, Mood, and Mild Cognitive Impairment?, J Alzheimers Dis, vol. 55, no. 3, pp. 1183-1193, 2017.